US$ 20.06
glp 1 hims and hers & swings to a loss in Q1 amid shift in GLP-1 strategy Despite the Stigma, Hims &
Description
June 4, 2021

The FDA's stated basis: a finding of no clinical need for 503B outsourcing facilities to compound these drugs from bulk substances

GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control

Step 7: Refill via consultation each time

"So it's forced upon the daughter or son" to talk to their parents about GLP-1s "because the primary care isn't doing the education," she says
